Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients
NCT04199715
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
Heplisav-B
Sponsor
Baylor Research Institute